CA2049649A1 - Codeine salt of a substituted carboxylic acid, processes for the preparation thereof, its use and pharmaceutical compositions - Google Patents

Codeine salt of a substituted carboxylic acid, processes for the preparation thereof, its use and pharmaceutical compositions

Info

Publication number
CA2049649A1
CA2049649A1 CA002049649A CA2049649A CA2049649A1 CA 2049649 A1 CA2049649 A1 CA 2049649A1 CA 002049649 A CA002049649 A CA 002049649A CA 2049649 A CA2049649 A CA 2049649A CA 2049649 A1 CA2049649 A1 CA 2049649A1
Authority
CA
Canada
Prior art keywords
salt
codeine
phenyl
formula
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002049649A
Other languages
English (en)
French (fr)
Inventor
Walter Riess
Alfred Sallmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2049649A1 publication Critical patent/CA2049649A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C07D489/04—Salts; Organic complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002049649A 1990-08-23 1991-08-21 Codeine salt of a substituted carboxylic acid, processes for the preparation thereof, its use and pharmaceutical compositions Abandoned CA2049649A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH2735/90-9 1990-08-23
CH273590 1990-08-23

Publications (1)

Publication Number Publication Date
CA2049649A1 true CA2049649A1 (en) 1992-02-24

Family

ID=4240432

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002049649A Abandoned CA2049649A1 (en) 1990-08-23 1991-08-21 Codeine salt of a substituted carboxylic acid, processes for the preparation thereof, its use and pharmaceutical compositions

Country Status (20)

Country Link
US (1) US5190947A (en, 2012)
EP (1) EP0472501B1 (en, 2012)
JP (1) JPH04257587A (en, 2012)
KR (1) KR920004391A (en, 2012)
AT (1) ATE137753T1 (en, 2012)
AU (1) AU652951B2 (en, 2012)
CA (1) CA2049649A1 (en, 2012)
DE (1) DE59107784D1 (en, 2012)
DK (1) DK0472501T3 (en, 2012)
ES (1) ES2086515T3 (en, 2012)
FI (1) FI96421C (en, 2012)
GR (1) GR3019872T3 (en, 2012)
HU (1) HU209308B (en, 2012)
IE (1) IE72479B1 (en, 2012)
IL (1) IL99213A (en, 2012)
NO (1) NO179175C (en, 2012)
NZ (1) NZ239495A (en, 2012)
PT (1) PT98731B (en, 2012)
TW (1) TW225536B (en, 2012)
ZA (1) ZA916642B (en, 2012)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0498011B1 (de) * 1991-02-07 1995-04-26 HEUMANN PHARMA GMBH & CO Neue Salze der 2-(2,6-Dichloranilino)-phenylessigsäure, Verfahren zu ihrer Herstellung und ihre Verwendung für topisch anwendbare pharmazeutische Zubereitungen
FR2708611B1 (fr) * 1993-07-29 1995-10-27 Meram Lab Sel de codéine de l'acide 2-(3-benzoylphényl)propionique, procédé d'obtention et compositions pharmaceutiques le contenant.
DE19607395C2 (de) * 1996-02-28 2002-11-21 Lohmann Therapie Syst Lts Salze aus einem kationischen narkotischen Analgetikum mit einem anionischen nichtnarkotischen Analgetikum, Verfahren zu deren Herstellung und die diese Salze enthaltenden pharmazeutischen Präparate
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
CA2304722C (en) * 1997-09-25 2005-11-22 Lts Lohmann Therapie-Systeme Ag Acidic addition salts of morphine alkaloids and the application thereof
AU2002305816B2 (en) * 2001-06-05 2008-04-10 Psivida Us Inc. Sustained-release analgesic compounds
US20030118528A1 (en) * 2001-11-19 2003-06-26 Walters Kenneth A. Topical delivery of codrugs
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US8840928B2 (en) * 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US8557291B2 (en) * 2002-07-05 2013-10-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opioids and other drugs
JP4694207B2 (ja) * 2002-07-05 2011-06-08 コルジウム ファーマシューティカル， インコーポレイテッド オピオイドおよび他の薬物に関する乱用抑止性の薬学的組成物
TW200500067A (en) * 2003-01-21 2005-01-01 Control Delivery Sys Inc Salts of codrugs and uses related thereto
CA2916869A1 (en) * 2004-06-12 2005-12-29 Jane C. Hirsh Abuse-deterrent drug formulations
US20090291121A1 (en) * 2008-05-23 2009-11-26 Symrise, Inc. Capsule and coated capsules as a delivery system for dietary supplements and therapeutic materials
BRPI1006222A2 (pt) 2009-03-12 2016-08-02 Cumberland Pharmaceuticas Inc uso de ibuprofeno na redução de dor em pacientes humanos que são submetidos a cirurgia, uso de ibuprofeno na redução de dor cirúrgica em pacientes humanos e uso de ibuprofeno para melhorar o tempo ambulatorial após a operação em pacientes humanos que sorem procedimentos cirúrgicos ortopédicos
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
WO2013112456A1 (en) 2012-01-24 2013-08-01 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Controlled release formulations for the induction and proliferation of blood cells
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA537946A (en) * 1957-03-12 J. Lewenstein Mozes Process for preparing improved compounds having narcotic effect
US936254A (en) * 1908-01-06 1909-10-05 Belden Mfg Co Attachment for telephones.
DE377588C (de) * 1922-08-29 1923-06-22 O Hinsberg Dr Verfahren zur Darstellung einer salzartigen Verbindung des Codeins
US2628185A (en) * 1949-04-01 1953-02-10 Lewenstein Mozes Juda Analgesic compounds and compositions
US3895063A (en) * 1965-04-08 1975-07-15 Ciba Geigy Corp Substituted Anilino Benzyl Alcohols
FR2051482B1 (en, 2012) * 1969-04-04 1973-06-08 Rabot Ets David
CA964192A (en) * 1970-07-21 1975-03-11 Roy H. Reiner Long-acting narcotic antagonist formulations containing pamoate salts of dihydronormorphinone
FR2257606B1 (en, 2012) * 1974-01-10 1978-02-24 Sumitomo Chemical Co
US4176186A (en) * 1978-07-28 1979-11-27 Boehringer Ingelheim Gmbh Quaternary derivatives of noroxymorphone which relieve intestinal immobility
DE2935776A1 (de) * 1979-09-05 1981-04-16 Theodor Prof. Dr. 4400 Münster Eckert Organische salze des indometacin, des naproxen und des diclofenac, ihre herstellung und sie enthaltende arzneimittel
AT370721B (de) * 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.

Also Published As

Publication number Publication date
FI96421B (fi) 1996-03-15
ZA916642B (en) 1992-04-29
NO179175B (no) 1996-05-13
IE912973A1 (en) 1992-02-26
IL99213A (en) 1995-07-31
HUT60501A (en) 1992-09-28
IE72479B1 (en) 1997-04-23
ATE137753T1 (de) 1996-05-15
PT98731A (pt) 1992-07-31
NO913295L (no) 1992-02-24
FI913949L (fi) 1992-02-24
HU209308B (en) 1994-04-28
JPH04257587A (ja) 1992-09-11
US5190947A (en) 1993-03-02
HU912768D0 (en) 1992-01-28
FI913949A0 (fi) 1991-08-21
FI96421C (fi) 1996-06-25
KR920004391A (ko) 1992-03-27
EP0472501B1 (de) 1996-05-08
ES2086515T3 (es) 1996-07-01
EP0472501A3 (en) 1993-02-24
DK0472501T3 (da) 1996-05-28
AU8268591A (en) 1992-02-27
IL99213A0 (en) 1992-07-15
PT98731B (pt) 1999-01-29
DE59107784D1 (de) 1996-06-13
NZ239495A (en) 1997-05-26
NO913295D0 (no) 1991-08-22
EP0472501A2 (de) 1992-02-26
GR3019872T3 (en) 1996-08-31
NO179175C (no) 1996-08-21
TW225536B (en, 2012) 1994-06-21
AU652951B2 (en) 1994-09-15

Similar Documents

Publication Publication Date Title
US5190947A (en) Codeine salt of a substituted carboxylic acid, its use and pharmaceutical compositions thereof
IL30394A (en) Phenylacetic acid derivatives
JPS59163400A (ja) ウルソデソキシコ−ル酸硫酸エステルのナトリウム塩
KR100422276B1 (ko) 치환된카복실산형태의음이온성비마취성진통제의모르핀염및디아모르핀염,이들의제조방법,이들의용도및이들염을포함하는제제
SK216092A3 (en) Using of xantine derivatives for treating of secondary lesions of neurous cells and functional defects after injuring of cranium and cerebrum
JPS6072843A (ja) ４−フエニル−４−オキソ−２−ブテン酸の新誘導体、それらの製造法、薬剤としての使用及びそれらを含む組成物
US3953601A (en) Dibenzothiophene derivatives as serum lipid lowering agents
EP0037187B1 (en) Salts and aqueous solutions of 6-methylamino-4-oxo-10-propyl-4h-pyrano(3,2-g)-quinoline-2,8-di-carboxylic acid and pharmaceutical compositions containing such salts and solutions
CH449652A (fr) Procédé de préparation de nouvelles hydroxydiamines
JPS5951954B2 (ja) インド−ル酢酸イソベンゾフラニルエステル、その製造方法及びそれを含有する鎮痛及び抗炎症剤
JP3252985B2 (ja) 抗潰瘍剤
SU1512482A3 (ru) Способ получени производных пиримидоизохинолина или их фармацевтически приемлемых солей
US4666912A (en) Treating process
US4094988A (en) Method of treating gastric ulcers using 5,6-dihydro-1,4-dithiinoxides
US3966960A (en) 3-(4-Biphenylcarbonyl)propionic acid as an inhibitor of platelet aggregation
KR920001762B1 (ko) 과요산혈증치료제
JPH06279432A (ja) 新規な化合物および該化合物を有効成分とする抗癌剤
US4332819A (en) Antiphlogistic agent and its use
JP2804445B2 (ja) 胃潰瘍および十二指腸潰瘍の処置剤および抗炎症剤
CN118217284A (zh) 3-芳基苯并呋喃衍生物在制备治疗类风湿关节炎药物中的应用
KR830002565B1 (ko) 5-(2-히드록시-3-티오프로폭시)크로몬-2-카르복실산류의 제조방법
EP0004686A2 (en) Anti-ulcer composition
JPS6144874B2 (en, 2012)
JPH07101857A (ja) ビタミンａ酸亜鉛塩を有効成分とする抗潰瘍剤
JPH0631207B2 (ja) ３，４−ジヒドロベンゾピラン誘導体類及びこれを有効成分とする抗消化性潰瘍剤

Legal Events

Date Code Title Description
FZDE Discontinued